ICML 2019 | Agressive or transformed MCL: prognostic factors, outcomes & mutational profile

Preetesh Jain

Preetesh Jain, MD, PhD, MD Anderson Cancer Center, Houston, Texas, TX, presents the comprehensive analysis of prognostic factors, outcomes and mutation profiles in patients with mantle cell lymphoma (MCL) with an aggressive histology (blastoid/pleomorphic) or transformed MCL. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Share this video